Top news of the week: 24.08.2022.
Biotech Looks to Bounce Back in Second Half of 2022
In the second half of the calendar year, the biopharma industry continues to ascend in mergers and acquisitions, new drug approvals and big investments, suggesting market confidence and ...
Downsized crop of 2022 US biopharma IPOs make gains amid correction
While there are significantly fewer initial public offerings in 2022 than in 2021 and 2020, the caution expressed by biopharma companies and investors seems to be paying off, with this year ...
Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder
The FDA approved a new treatment that delivers a potentially permanent, genetic fix for patients with the inherited blood disorder beta thalassemia.
Protein From Pig's Skin Could Help Treat Blindness: Research
The protein implant from pig skin has successfully helped treat blindness among study participants, according to researchers.
Mereo Under Fire As Shareholder Unrest Erupts
<p>The UK biotech is developing three key assets - <span></span>setrusumab, alvelestat and etigilimab - but according to its biggest stockholder, the progress being made is too slow and the ...
Everest Refocuses After Trodelvy Twist
<p><span>A shift in investor sentiment in 2021 hit Everest hard when it was expanding the commercial team for cancer drug Trodelvy. Entering 2022, the sustained downturn in the capital ...
Ethanol could get boost from carbon capture credits in Biden climate law
A major expansion in tax credits for companies that capture and store carbon emissions under U.S. President Joe Biden's new climate law could be a boon to the ethanol industry as it seeks ...
Animal Models for the Development of Cancer Immunotherapy
Animal Models for the Development of Cancer Immunotherapy Provides readers with a clear understanding of the value and challenges of using common and emerging preclinical models in cancer ...